Page 20«..10..19202122..3040..»

Shout Out: Dasha Ignatova, co-founder of healthy lifestyle club at Buffalo Grove High School – Chicago Tribune

Buffalo Grove High School student Dasha Ignatova and other founding members have been surprised by the rapid success of the school’s healthy lifestyle club that they helped start one year ago.

Beginning in fall 2016, the Elevate club, a school chapter of the national Life of an Athlete program, started with eight founding members but by the spring, the group totaled 200 members, the students said. Earlier this summer, the Life of an Athlete organization awarded the Buffalo Grove High School group with its “Program of the Year” honor.

“It was a huge surprise,” Ignatova said of the award. “We’re just trying to encourage other kids that there are better options than partying. The realization for others is the most important part for us.”

It would be easy to pigeonhole the Elevate group as an anti-drugs club, but some of the founding members have said the message goes beyond that. Life of an Athlete and its chapters also try to teach students about the importance of healthy diets and sleep.

As Ignatova, who is an incoming senior and student athlete from Arlington Heights, and other founding members described it, Elevate teaches its members to take care of their bodies as a means toward taking care of their teammates.

Ignatova recently talked with Pioneer Press about the Elevate chapter as she and other seniors prepare students to lead the group once some of the senior members graduate. She said she plans to study chemical engineering in college after her senior year at Buffalo Grove High School.

Q: How do you keep in touch with so many kids?

A: It was more of an honor system. We have a pledge and if you sign it, you’re saying you will be honest to it and to the other people who signed it. We talked with three or four kids about problems they had.

Q: Chemical engineering sounds important and lucrative. What is it?

A: You can work with different pharmaceuticals. You can work for companies that create hair sprays or medicine, or different bottled products. I’ve always felt that medicine is something that can be improved on. Something that has less side effects, or is better for your body.

Q: A high school kid somewhere hears about Life of an Athlete and wants to start a chapter. How does that kid replicate Elevate’s success?

A: It only takes one person to make a change. Once his teammates realize, “Wow, this kid is excelling. He’s the strongest one out of us all,” and he might not be the greatest athlete, “Maybe, I should do what he’s doing.” And I’d tell the kid, “You don’t need to force other people to do this.”

Shout Out is a weekly feature in which we introduce our readers to their fellow community members and local visitors throughout suburban Chicago.

RWachter@PioneerLocal.com

Twitter @RonnieAtPioneer

More:
Shout Out: Dasha Ignatova, co-founder of healthy lifestyle club at Buffalo Grove High School – Chicago Tribune

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Simple changes to begin a ‘heart-healthy’ lifestyle – WZZM

Brittany Foster, WZZM 10:06 AM. EDT August 01, 2017

GRAND RAPIDS, MICH. – With summer slowing down and plans for another school year just around the corner, now is a great time for your family to get back to some healthier habits.

Dr. Vinayak Manohar, cardiologist at Mercy Health Physician Partners, stopped by The Exchange to share some simple tips on how to start eating your way to a heart-healthy lifestyle.

Dr. Manohar suggests adding more vegetables to your plate, switching to whole grains, and when it comes to meat in your diet, trying to stick to mostly poultry or fish.

For more tips and for more on Mercy Health, click here.

Make it easy to keep up to date with more stories like this. Download the WZZM 13 app now.

Have a news tip? Email news@wzzm13.com, visit our Facebook page or Twitter.

2017 WZZM-TV

Go here to read the rest:
Simple changes to begin a ‘heart-healthy’ lifestyle – WZZM

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

‘Blazing the trail’: University of Calgary research could lead to cures for autoimmune diseases – CBC.ca

Researchers at the University of Calgary say their work in the field of “nanomedicine”could lead to cures for Type 1 diabetes, multiple sclerosis and many more diseases.

Dr. Pere Santamaria said the process involves “nanoparticles” thousands of times smaller than a typicalhuman cell that could be used to stop the body from attacking itself.

That, he said, could potentially lead to cures for autoimmunedisorders.

“There are no drugs that can do that today,”said Santamaria, aprofessor ofimmunology at the University of Calgary.

“Other drugs that are being used to treat chronic inflammatory disorders impair the ability of the immune system to do its job, so there are secondary effects and longterm complications our drugs don’t do that.”

Pharmaceutical company Novartis has partnered with Santamaria’s own company, Parvus Therapeutics, to work on developing the nanomedicines and take the drugs to market.

Now with support and funding, Santamariasaid the new drug”has the potential to revolutionizemedicine” if the drugs pass clinical testing.

Santamariasaid autoimmune disordersarecaused by white blood cells attacking the tissues in a person’sown body.

Pharmaceutical company Novartis has partnered with Dr. Santamaria’s Parvus Therapeutics to work on developing nanomedicines to cure autoimmune disorders and take the drugs to market. (CBC)

Type 1 diabetesis treatable with insulin, but there is no cure. It’s the same for many other diseases.

“Our drugs aim to resolve the inflammation of the tissue, the attack of the tissue, and resolve that process altogether,” Santamaria said.

He said the nanoparticles could halt disorders without impairing the rest of the immune system.

“So we can reset the immune system to its steady state that means the healthy state without impairing the ability of our immune system to protect us against infections and cancer,”Santamariasaid.

Santamaria said the nanoparticleswere discovered during an experiment years ago, and the initialtestresults”made nosensewhatsoever.” Since that day, the nanomedicines havebeen in development and he credits the progress to curiosity.

“We almost shoved them under the rug,” Santamaria said.”We didn’t do that. Fortunately, we were pursued wth curiosity of researching.”

Santamaria said the process of taking a discovery from the research laboratory to the marketplace is enormously complex and the drug has yet to go through preclinical trials.

Because nanomedicine is such a new field of research, there is no firm timeline on when the medicinescould be available if they pass human trials.

“Our nanomedicineis a new class of drug … so we’re basically blazing the trail,” Santamaria said.

“We hope that we can carry that torch and be an example for all the investigators that might follow suit, that may run into discoveries such as the ones that we’ve made and hopefully they can follow in our footsteps.”

View original post here:
‘Blazing the trail’: University of Calgary research could lead to cures for autoimmune diseases – CBC.ca

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Carson City nutrition factory to collaborate education with products – Nevada Appeal

Maria Watson wants Carson City to know she’s back in business and is determined to bring the community quality health education, along with the relaunch of her company.

Formerly known as Vitamin Research Products, the CEO and president is reintroducing her natural vitamin supplement line as American Nutritional Products after a two year hiatus.

From stress relievers to belly busters, Watson’s multivitamin products are manufactured with formulas containing plant-based ingredients, FDA approved.

Now that she’s returned, she hopes to connect with the local community such as schools, churches, and other organizationsto teach the benefits of a healthy lifestyle and how to achieve it, while promoting her product.

Specifically, she hopes to target families and single parents, as nearly a third of the country spends dollars on fast-food and restaurant services, according to USDA.

Whether seminars take place at community colleges, health centers, or even at her facility, Watson hopes to fulfill one’s health goals and produce new jobs in the area.

“It’s been a painful and long journey,” she said. “But this community helped us the first time and I want to educate as a way to give back.”

When her company used to be Vitamin Research, Watson and her husband, Ron, supervised the facility on Highway 50 East in 2012, before constructing a larger building at 4610 Arrowhead Drive.

Back then, the company employed 127 people and packaged at least 3,000 products per day.

However, regulatory climate became a concern, to a point where the private equity group supporting Watson’s company announced closure in July 2015. That closure led to the closure of Vitamin Research.

Now with 23 returning employees, Watson is preparing to get her manufacturing business up and running under the new name.

“My dream came true, but the rooms are empty.” she said.

As for Watson’s longtime customers, they’re elated over the news of the original founder’s return.

Jana Kay of Reno said she appreciates the natural ingredients the company uses in the multivitamins, as she couldn’t find desired quality products in grocery stores or pharmacies.

“She’s on a mission and wants to educate peoplewe need to educate people. That’s why I was inspired to study nutrition and psychology in college, and learn about eating disorders within mental health.”

Although Watson is a nutritional guru, what truly inspired her to get into the industry was her son, Josh, whom died at the age of 3 in 1987.

“He died in a car accident caused by a drunk driver, his babysitter,” she said. “When he died, I gained 199 pounds and went through depression. But I knew I couldn’t be like this foreverI believed I could change the world with my passion, and I still feel that way.”

Watson is developing a plan for international collaboration. She connected with Deborah Torres Patel, a high prolific communication coach based out of Singapore.

Patel is known for mentoring best selling authors, entrepreneurs and leaders of Fortune 500 companies, and numerous celebrities in 79 countries.

Patel has never been to Carson City until last month when she met with Maria to help her develop a draft on how to combine health and education within the company.

One of Watson’s ideas is to teach ways to relieve stress and anxietywith public speaking being a start.

“84 percent of first-time impressions is based on your tone of voice,” Patel said. “It also affects how you feel and that’s why I created my system to find your voice; you only get one chance to make a first impression.”

Patel and Watson also discussed ways to collaborate education with new products, such as consumables or water with a natural ingredients to support energy boosts.

“It’s about essential integrity and work,” Watson said. “Why not amplify that in Carson City? People that live here are active. I want to educate those that will listen.”

Watson advises the public to watch for future job announcements as the company grows.

For more information, contact Watson at 775-720-0028 or maria.watson@anp-nv.com.

Continue reading here:
Carson City nutrition factory to collaborate education with products – Nevada Appeal

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

International Conference and Exhibition on Nanomedicine and Nanotechnology – Technology Networks

Short Name: Nanomed Meeting 2017

Theme: Challenges and Innovations in next generation medicine

Website: http://www.meetingsint.com/pharma-conferences/nanomedicine-nanotechnology

Registration Link: http://www.meetingsint.com/pharma-conferences/nanomedicine-nanotechnology/registration

Nanomed Meeting 2017 Organizing Committee invites you to attend the largest assemblage of Nanomedicine and Nanotechnology researchers from around the globe during November 23-24, 2017 at Dubai, UAE.

Nanomed Meeting 2017 is a global annual event. This International Conference and Exhibition on Nanomedicine and Nanotechnology brings together scientists, researchers, business development managers, CEOs, directors, IP Attorneys, Regulatory Officials and CROs from around the world. The passage of Nanomed Meeting 2017 through a decade at Asia finds much requirement for discussion also focusing the latest developments in the field of Nanomedicine and Nanotechnology.

Why attend?

Join your peers around the world focused on learning about Nanomedicine and Nanotechnology related advances, which is your single best opportunity to reach the largest assemblage of participants from the Nanomedicine and Nanotechnology community, conduct demonstrations, distribute information, meet with current and potential professionals, make a splash with a new research works, and receive name recognition at this 2-day event. World-renowned speakers, the most recent research, advances, and the newest updates in Nanomedicine and Nanotechnology are hallmarks of this conference.

Like what you just read? You can find similar content on the communities below.

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

Read more:
International Conference and Exhibition on Nanomedicine and Nanotechnology – Technology Networks

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Cancer survivor becomes a cancer fighter at a Philly start-up – Philly.com

What Debra Travers really wanted to be was a marine biologist, until I found out Jacques Cousteau wasnt hiring.

How she wound up as chief executive of PolyAurum LLC, a Philadelphia start-up developing biodegradable gold nanoparticles for treating cancerous tumors, involved a professional journey of more than 30 years in pharmaceutical and diagnostics industries, and a personal battle with the disease shes now in business to defeat.

After determining that studying sea creatures was not a viable career choice, Travers a military kid from all over switched her major at Cedar Crest College in Allentown to medical technology. She graduated in 1979, then worked for three years in a hospital laboratory until she concluded she didnt like shift work and could do more.

What followed was an impressive career progression: Travers started as a chemistry technician at DuPont Biomedical Products Division, advancing to executive positions in marketing and product development at Centocor, GlaxoSmithKline, Endo Pharmaceuticals, and IMS Health.

Much of that work involved bringing new products through the long development and regulation-heavy process from concept to launch, with experience in therapeutic areas including oncology, urology, pain medicine, cardiology, and rheumatology. In an industry of specialty silos, Travers developed a uniquely blended expertise in marketing and R&D.

It was on March 23, 2006, that her health-care vocation turned personal: Travers, then a 50-year-old mother of two, was diagnosed with breast cancer.

An oncologist recommended a double mastectomy, removal of both ovaries, and chemotherapy. The tearful pleadings of her daughter, Kelly, then 18 I need you here when I graduate college, when I get married, when I have kids persuaded Travers to follow that recommendation.

She returned to work at Endo for seven more years, as a director in project management, before being laid off in June 2013, one month before her daughters wedding. The break gave Travers time to concentrate on the big event and to start to think what Id like to do when I grow up.

That process would lead her in late 2015 to PolyAurum, a start-up spun out of the University of Pennsylvania.

I became a CEO and a grandmother in the same year, said Travers, now 61, chuckling during a recent interview at the Pennovation Center incubator in West Philadelphia. From there, her home in Delaware, and the sites of pitch opportunities with investors, she is working to raise $1.3 million in seed funding by early in the fourth quarter, to help get PolyAurum closer to clinical trials on humans.

So far, research and testing funded through $4 million in grants to the university has been limited to mice with tumors. It has shown that gold nanocrystals greatly enhance the effectiveness of radiation on tumors without increasing harm to healthy surrounding tissue, said Jay Dorsey, an associate professor and radiation oncologist at Penn and one of four university faculty who developed the technology.

The effectiveness of metals in improving a tumors ability to absorb radiation has long been known, Dorsey said. But one of the stumbling blocks to incorporating gold nanoparticles in such therapeutics is that the metal is not eliminated from the body well, posing serious problems to vital organs such as the liver and spleen.

Penns David Cormode, a professor of radiology, and Andrew Tsourkas, a professor of bioengineering, have worked to make gold more biocompatible, resulting in PolyAurums current technology, Dorsey said. The gold nanocrystals are contained in a biodegradable polymer that allows enough metal to collect in a tumor. The polymer then breaks down, releasing the gold for excretion from the body so that it does not build up in key organs.

The companys name is a combination of those two essential ingredients: Poly, derived from polymer, and Aurum, the Latin word for gold.

Explaining all that, and the potential that PolyAurums founders see for extending and saving lives, is the message Travers now is in charge of disseminating the part of the critical path to commercialization that is not the strength of most researchers toiling in laboratories.

She knows what the founders dont know it just makes a perfect match, said Michael Dishowitz, portfolio manager at PCI Ventures, an arm of Penn that helps university start-ups find investors, recruit management, and get to market.

Since its formation about eight years ago, PCI has helped more than 150 companies secure more than $100 million in funding, said Dishowitz, who has a doctoratein bioengineering from Penn and spent several years studying the impact of cell-signaling pathways on orthopedic injury.

While calling PolyAurums technology cool and very transformative for treatment, Dishowitz also delivered a dose of reality about the rigors ahead, as health-care start-ups must navigate a course with no guarantees their products will lead to actual clinical implementation.

PolyAurum is one of 13 companies that entered Philadelphia Media Networks second annual Stellar StartUps competition in the health-care/life sciences category. A total of nine categories drew 88 applicants. The winners will be announced Sept. 12 at an event at the Franklin Institutes Fels Planetarium. (Details at http://www.philly.com/stellarstartups.)

A lot has to go right, all the planets and stars have to align for this to hit the market, Dishowitz said of PolyAurums commercial prospects.

Which is why the team behind any start-up is so essential to investors, he said, calling Travers interest in joining a company that has yet been unable to pay her (she has equity in PolyAurum) incredibly lucky.

Margo Reed

At the Nanomedicine and Molecular Imaging Lab at Penn Medicine are (front row, from left) Jay Dorsey, a radiation oncologist and a founder of PolyAurum; Debra Travers, CEO; and Andrew Tsourkas, another founder of PolyAurum; and (back row, from left) Michael Dishowitz, portfolio manager, PCI Ventures at Penn; and David Cormode, lab director and PolyAurum founder. (MARGO REED / Staff Photographer)

The only thing Travers corporate-heavy background lacked, he said, was raising money for a start-up. It doesnt worry him, Dishowitz said, citing Travers perseverance, no-quit attitude.

When youre out there raising money, youre going to hear no about 100, 150 times before you hear yes, Dishowitz said.

When it comes to pitching for PolyAurum, Travers has extra incentive.

I am working on a cancer therapeutic, which is very important to the 11-year cancer survivor in me, she said.

As for handling nos, shes had plenty of professional experience with that.

After spending 30-plus years in the drug and diagnostic industries, where it is hard to find women CEOs or board members, Travers said, Ive learned to ignore the negative voices.

When: 5:30-8:30 p.m. Tuesday, Sept. 12.

Where: Fels Planetarium, Franklin Institute, 222 N. 20th St., Philadelphia 19103

For more information: http://www.philly.com/stellarstartups

Published: July 28, 2017 3:01 AM EDT

We recently asked you to support our journalism. The response, in a word, is heartening. You have encouraged us in our mission to provide quality news and watchdog journalism. Some of you have even followed through with subscriptions, which is especially gratifying. Our role as an independent, fact-based news organization has never been clearer. And our promise to you is that we will always strive to provide indispensable journalism to our community. Subscriptions are available for home delivery of the print edition and for a digital replica viewable on your mobile device or computer. Subscriptions start as low as 25 per day.We’re thankful for your support in every way.

See more here:
Cancer survivor becomes a cancer fighter at a Philly start-up – Philly.com

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Application of Nanomaterials in the Field of Medicine – Medical News Bulletin

There has been a growing interest in the different applications of nanomaterials in the field of medicine. An article published in Nanomedicine: Nanotechnology, Biology, and Medicine showed the ways in which Laponite, a synthetic clay made of nanomaterials, can be of use in clinical practice.

Current advances in technology have provided many opportunities to develop new devices that improve the practice of medicine. There has been a growing interest in the different applications of nanomaterials in the field of medicine.

An article published in Nanomedicine: Nanotechnology, Biology, and Medicine reviewed Laponite, a non-toxic synthetic clay composed of nanomaterials which has different uses in the field of medicine. Laponite can be used in drug delivery systems, as the synthetic clay protects substances from degradation in physiologic environments. Different experiments show that Laponite is effective not only in protecting drugs from degradation, but also in transporting and releasing drugs into the body. The degradation of Laponite in the physiologic environment also releases products which have biological roles, especially in bone formation.

Laponite has been shown to induce osteogenic differentiation of cells in the absence of other factors which are known to promote differentiation and cell growth. The application of nanomaterials in bioimaging has also been studied. In one experiment, Laponite was incorporated with gadolinum, a dye used in magnetic resonance imaging (MRI), resulting in brighter images and prolonged contrast enhancement for 1 hour post-injection. Laponite has also proven to be of use in the field of regenerative medicine and tissue engineering. This synthetic clay can elicit specific biologic responses, act as a carrier for biochemical factors, and improve the mechanical properties of scaffolds used for tissue growth.

In summary, nanomaterials and synthetic clays such as Laponite have many applications in the field of medicine. Although current published literature state no toxic effects on the human body, further studies are needed to assess safety before it can be applied to clinical practice.

Written By:Karla Sevilla

Add to Flipboard Magazine.

See the rest here:
Application of Nanomaterials in the Field of Medicine – Medical News Bulletin

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Testosterone Replacement Therapy Market Research Strategy 2017 – Equity Insider (press release)

Global Testosterone Replacement Therapy Market Research Report 2017 to 2022presents an in-depth assessment of the Testosterone Replacement Therapy including enabling technologies, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents forecasts for Testosterone Replacement Therapy investments from 2017 till 2022.

This study answers several questions for stakeholders, primarily which market segments they should focus upon during the next five years to prioritize their efforts and investments. The Testosterone Replacement Therapy markets are highly fragmented due to the presence of numerous small and large vendors. Most of the international pharmaceutical companies are facing challenges such as price pressure, regulatory constraints, and competition from local and other international pharmaceutical companies in the Testosterone Replacement Therapy markets. The competitive environment in the market is expected to intensify with an increase in product extensions, technological innovations, and increase in mergers and acquisitions.

These stakeholders include Testosterone Replacement Therapy manufacturers such as : AbbVie, Pfizer, Eli Lilly, Teva Pharmaceuticals, Mylan, Bayer HealthCare Pharmaceuticals, Antares Pharma, Ferring Pharmaceuticals, Allergan, Antares Pharma, Sandoz, Clarus Therapeutics, Juniper Pharmaceuticals, Endo International, Acerus Pharmaceuticals, Forendo Pharma, MetP Pharma, Repros Therapeutics.

Inquire for sample of report @:

https://www.marketinsightsreports.com/reports/07317183/global-testosterone-replacement-therapy-market-research-report-2017/inquiry

Primary sources are mainly industry experts from core and related industries, and suppliers, manufacturers, distributors, service providers, and organizations related to all segments of the industrys supply chain. The bottom-up approach was used to estimate the global market size of Testosterone Replacement Therapy based on end-use industry and region, in terms of value. With the data triangulation procedure and validation of data through primary interviews, the exact values of the overall parent market, and individual market sizes were determined and confirmed in this study.

Secondly the study, besides estimating the Testosterone Replacement Therapy market potential till 2022, analyzes on who can be the market leaders and what partnerships would help them to capture the market share. The report gives an overview about the dynamics of the market, by discussing various aspects such as drivers, restraints, Porters 5 forces, value chain, customer acceptance and investment scenario.

TheGlobal Testosterone Replacement Therapy marketconsists of different international, regional, and local vendors. The market competition is foreseen to grow higher with the rise in technological innovation and M&A activities in the future. Moreover, many local and regional vendors are offering specific application products for varied end-users. The new vendor entrants in the market are finding it hard to compete with the international vendors based on quality, reliability, and innovations in technology.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

Global Testosterone Replacement Therapy Sales (K Units) and Revenue (Million USD) Market Split by Product Type:

Global Testosterone Replacement Therapy Sales (K Units) by Application (2016-2022)

by Application

(2016-2022)

The research provides answers to the following key questions:

This independent 112 page report guarantees you will remain better informed than your competition. With over 150 tables and figures examining the Testosterone Replacement Therapy market, the report gives you a visual, one-stop breakdown of the leading products, submarkets and market leaders market revenue forecasts as well as analysis to 2022.

Browse Full Report @:

https://www.marketinsightsreports.com/reports/07317183/global-testosterone-replacement-therapy-market-research-report-2017

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), and market share and growth rate of Storage Area Network Switch in these regions, from 2012 to 2022 (forecast), covering

by Regions

The report provides a basic overview of the Testosterone Replacement Therapy industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures.

Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specifications, sales, market share and contact information. Whats more, the Testosterone Replacement Therapy industry development trends and marketing channels are analyzed.

The report segments this market based on products, portability, methods, applications, and end users. Among various end users, the hospitals segment is expected to account for the largest share of the market and is expected to grow at the highest CAGR from 2014 to 2019. The high growth in this segment can be attributed to the rising rate of maternal mortality and fetal birth defects, and increasing number of initiatives taken by government organizations for improving prenatal care.

The research includes historic data from 2012 to 2016 and forecasts until 2022 which makes the reports an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs. The report will make detailed analysis mainly on above questions and in-depth research on the development environment, market size, development trend, operation situation and future development trend of Testosterone Replacement Therapy on the basis of stating current situation of the industry in 2017 so as to make comprehensive organization and judgment on the competition situation and development trend of Testosterone Replacement Therapy Market and assist manufacturers and investment organization to better grasp the development course of Testosterone Replacement Therapy Market.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

There are 15 Chapters to deeply display the global Testosterone Replacement Therapy market.

Chapter 1, to describe Testosterone Replacement Therapy Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Grain and Seed Cleaning Equipment, with sales, revenue, and price of Grain and Seed Cleaning Equipment, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Grain and Seed Cleaning Equipment, for each region, from 2012 to 2017;

Chapter 5, 6, 7,8and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Testosterone Replacement Therapy market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 13, 14 and 15, to describe Testosterone Replacement Therapy sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.

Read the rest here:
Testosterone Replacement Therapy Market Research Strategy 2017 – Equity Insider (press release)

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Understand how hormone levels might affect your quality of life – Palm Beach Post

Regardless of gender, all humans produce the hormone testosterone. However, men have much higher levels of testosterone than women.

Testosterone is a chemical messenger that is responsible for the development of male sexual characteristics. In addition, testosterone helps regulate muscle size and strength, red blood cell production, bone mass, and fat distribution.

As men age, their testosterone levels begin to dip. Although a natural result of aging, lower testosterone levels, also called hypogonadism, can contribute to any number of side effects – some of which men can find interrupt their quality of life. The medical resource Healthline says that testosterone starts to decrease after age 30, falling by 1 percent for each year thereafter.

Some men may even suffer from low testosterone (called low-T), which is the underproduction or lack of production of this hormone. Typically, this is linked to chronic medical conditions, such as obesity, diabetes and other hormonal conditions. Although not all men will experience low-T, learning to recognize its signs and symptoms can help those who develop the condition address it that much more quickly.

Changes in sexual function: Changes in sexual function resulting from low-T can include decreased libido/desire, inability to have or maintain erections, fewer spontaneous erections, and infertility. Since testosterone is linked to healthy sperm production, lower levels may reduce the number of healthy sperm or their mobility.

Insomnia and trouble sleeping: Sleep disturbances may be linked to low-T. These can include trouble falling asleep or frequent waking.

Weight gain: Men with low-T may suffer from increased body fat coupled with decreased energy levels that can make exercise less appealing. Weight gain particularly in the abdominal area may also occur in conjunction with a condition called gynecomastia, which is swollen or tender breasts.

Reduced muscle mass: Other physical changes can include reduced muscle bulk and strength. Decreased bone mass or mineral density is also possible.

Emotional changes: Emotional changes may be a byproduct of lower testosterone or feelings of helplessness over a seemingly irreversible condition. Fatigue, low self-confidence, sadness, depression, and even trouble concentrating are possible.

The Urinary Care Foundation says that low-T is quite common. Roughly 4 out of 10 men over the age of 45 have low testosterone. Low-T also affects 2 out of 10 men over the age of 60 and 3 out of 10 men over the age of 70.

If symptoms of low-T prove bothersome, testosterone replacement therapy, or TRT, may be prescribed. These include skin gels, shots, long-acting pellets, patches, and pills. The American Urological Association suggests discussing the pros and cons of TRT with a doctor who is skilled in diagnosing low-T. TRT should not be used by men planning to become a father anytime soon.

It should be noted that, while the Mayo Clinic says there are no definitive studies that point to HRT being effective, the accumulation of anecdotal evidence is undeniable.

Local anti-aging and regenerative medicine expert Dr. Brett Osborn believes that while HRT is not for everyone for instance, those with a strong family history of hormone-sensitive cancer if you and your physician do opt for HRT, use only bio-identical hormones.

Bio-identical hormones are those that are created in a compounding pharmacy and match ones own specific hormonal needs.

In addition, he strongly urges that you avoid ever using oral testosterone or oral estrogens because both, when broken down metabolically, have the potential to be carcinogenic.

Rather, he suggests that bio-identical transdermal creams or injections are the best options.

Do not underestimate the roles that hormones play in your biochemistry and your overall well-being. I would urge everyone to explore with their doctor the option of hormone replacement therapy. Restoring a youthful hormone profile not only has the potential to make you feel great, but also may slow down the aging process.

And just in case you need further proof of Dr. Osborns belief in HRT, consider this: He checks his own hormone levels every six weeks and adjusts his HRT accordingly.

Read the original:
Understand how hormone levels might affect your quality of life – Palm Beach Post

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

The global testosterone replacement therapy industry is fertile – WhaTech

This report estimates the drivers, restraints, and opportunities pertaining to the global Testosterone Replacement Therapy market over the timeframe of 2016-2022. Delivering the key insights pertaining to this industry, the report provides an in-depth analysis of the latest trends, present and future business scenario, market size and share, and commercialization potential of the Testosterone Replacement Therapy industry over the coming five years.

This Testosterone Replacement Therapy Marketreport values the industry in USD million terms for 2016, expected USD million value by the end of 2022 is provided, showing a steady CAGR percentage number between 2016 and 2022.

Request a Sample Copy of Global Testosterone Replacement Therapy Market Research Report @ http://www.marketstudyreport.com/request-a-sample/478872//?utm_source=WAT-SP

The competitive landscape of the Testosterone Replacement Therapy market profiles the key players participating in the global business space.

The report also details the market positioning, strategies, and revenue procured by each of these manufacturers.

The industry is analyzed in terms of products, applications, regions, and the key manufacturers holding a prominent share of the global revenue.

The product landscape of the Testosterone Replacement Therapy market comprises Gels, Injectables, Patches and Other. Each product has been analyzed in terms of its production, capacity, and consumption.

The report further details the market share to be procured by each of these products over the coming years.

Enquire about this report @ http://www.marketstudyreport.com/check-for-discount/478872//?utm_source=WAT-SP

In terms of end-user or applications, the report is segmented into Hospitals, Clinics and Other. A detailed analysis of the contribution of these application segments to the overall market revenue and volume has been included in the report.

The regional segmentation of the report includes North America, Europe, China, Japan, Southeast Asia and India. Detailing the consumption and production rate of Testosterone Replacement Therapy in these regions, the report outlines the growth curve of this industry in terms of market volume and share over 2016-2022.

Major Points in Table of Contents

Global Testosterone Replacement Therapy Market Research Report 2017

Testosterone Replacement Therapy Market Overview

Global Testosterone Replacement Therapy Market Competition by Manufacturers

Global Testosterone Replacement Therapy Capacity, Production, Revenue (Value) by Region (2012-2017)

Global Testosterone Replacement Therapy Supply (Production), Consumption, Export, Import by Region (2012-2017)

Global Testosterone Replacement Therapy Production, Revenue (Value), Price Trend by Type

Global Testosterone Replacement Therapy Market Analysis by Application

Global Testosterone Replacement Therapy Manufacturers Profiles/Analysis

Testosterone Replacement Therapy Manufacturing Cost Analysis

Industrial Chain, Sourcing Strategy and Downstream Buyers

Marketing Strategy Analysis, Distributors/Traders

Market Effect Factors Analysis

Global Testosterone Replacement Therapy Market Forecast (2017-2022)

Research Findings and Conclusion

Related Reports: -

United States Testosterone Replacement Therapy Market Report 2017

This report studies sales (consumption) of Testosterone Replacement Therapy in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

http://www.marketstudyreport.com/reports/united-states-testosterone-replacement-therapy-market-report-2017//?utm_source=RR-SP

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:

Market Study Report

The Green Suite #4594,

Dover, DE 19901

United States

Phone:1-201-355-0868

US Toll Free:1-866-764-2150

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Website: http://www.marketstudyreport.com

News: http://www.marketstudyreport.com/category/news-releases/

Connect with us: Google+ | LinkedIn | Twitter

See the original post here:
The global testosterone replacement therapy industry is fertile – WhaTech

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...